| Bertozzi, Carolyn |
Stanford University
United States |
Chemical Glycoproteomics |
5R01CA200423-20 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
| Eibl, Guido Erwin Michael |
University Of California Los Angeles
United States |
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma |
5P01CA236585-04 |
PAR-18-290 (P01 Clinical Trial Optional) |
|
| El-Bayoumy, Karam E |
Pennsylvania State Univ Hershey Med Ctr
United States |
Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies |
5R01CA173465-10 |
|
|
| Shen, Qiang |
Lsu Health Sciences Center
United States |
Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 |
5R01CA226001-06 |
|
|
| You, Ming |
Methodist Hospital Research Institute
United States |
Chemoprevention of lung cancer by targeting lonidamine to mitochondria |
5R01CA232433-05 |
|
|
| Pyter, Leah M |
Ohio State University
United States |
Chemotherapy-induced circadian master clock disruptions and fatigue |
3R01CA270372-02S1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
| Olopade, Olufunmilayo F. |
University Of Chicago
United States |
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA) |
1R01CA276652-01A1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Pollock, Brad H |
Public Health Institute
United States |
Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base Grant |
3UG1CA189955-10S2 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Levine, Jon David |
University Of California, San Francisco
United States |
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress |
5R01CA250017-05 |
|
Rachel Altshuler, Ph.D. |
| Valdez, Erin G |
Stanford University
United States |
Circadian regulation of cancer therapy-associated neuroinflammation |
5R21CA267135-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|